MedTrace Logo

Identification of New Markers in the Hypereosinophilic Syndrome

NCT01713504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2026-01-08

No results posted yet for this study

Summary

The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.

Conditions

  • Hypereosinophilic Syndrome

Interventions

BIOLOGICAL

biologie sample

comparison of biomarkers between HES, HE biomarkers data and control arms

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Lionel Prin, MD PhD · University Hospital, Lille

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-29
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01713504 on ClinicalTrials.gov